Raytheon CEO Says Region Needs to Improve Its Missile Defense Systems

Dr. Thomas Kennedy, CEO and Chairman of Raytheon (Asharq Al-Awsat)
Dr. Thomas Kennedy, CEO and Chairman of Raytheon (Asharq Al-Awsat)
TT

Raytheon CEO Says Region Needs to Improve Its Missile Defense Systems

Dr. Thomas Kennedy, CEO and Chairman of Raytheon (Asharq Al-Awsat)
Dr. Thomas Kennedy, CEO and Chairman of Raytheon (Asharq Al-Awsat)

Thomas Kennedy, chairman and CEO of Raytheon, a defense and security firm, said his company’s Saudi branch was planning to nationalize the military industry in the Kingdom.

He stressed, however, that the nationalization procedures would not be limited to manufacturing, but would also include design and development, especially in the areas of integrated air and missile defenses, air traffic control systems, security systems and cybersecurity.

In an interview with Asharq Al-Awsat on the sidelines of an aviation exhibition in London, Kennedy revealed that Raytheon was seeking to develop joint projects in various aspects of military action in Saudi Arabia.

He revealed that work was underway to develop the Kingdom’s capabilities in the field of cybersecurity and implement a strategy aimed at nationalizing the military industries by 50 percent in the future.

As for the air support systems, he noted that Raytheon would strengthen Saudi defense capabilities under a joint venture with the Saudi Military Industries Company and would cooperate with the Cyber Security Company appointed by the Saudi government to develop this area.

Cybersecurity is a major part of Raytheon’s work, according to the CEO, who highlighted an MoU signed with Saudi Aramco that would enable the two sides to work together to create effective solutions in cybersecurity.

Raytheon is a New York-listed technology and innovation company specializing in defense, security and civil markets around the world. Based in Waltham, Massachusetts, the company achieved sales of $25 billion in 2017 and has a workforce of about 64,000 employees worldwide.

Kennedy said the company has been cooperating with Saudi Royal Air Defense Force and Saudi Royal Air Force for many years, adding that it was currently working with other military institutions, the Ministry of the Interior and Saudi Aramco. He emphasized that the establishment of Saudi Raytheon was part of the efforts of Crown Prince Mohammed bin Salman, Deputy Prime Minister and Minister of Defense, to achieve the Kingdom’s Vision 2030.

Asked about the company’s work in the United Arab Emirates, the chairman stressed that the UAE has been Raytheon’s partner for 31 years, during which Raytheon UAE was established and would be run by Emiratis with the goal of nationalizing the company.

As for the growth of Raytheon’s works, Kennedy revealed that the company concluded 2017 with a 32 percent growth in its international sales, the 14th consecutive year of growth.

The region is witnessing an urgent need to improve the capabilities of integrated air and missile defenses, according to the CEO. As Yemen’s conflict is threatening both Saudi Arabia and the UAE, the two countries demand solutions to protect their sovereignty and ensure the safety of their peoples, he explained.

Raytheon, established nearly 95 years ago, provides electronic devices, mission systems, command and control products, computers, cybersecurity and sensor systems, effects and task support, and operates in more than 80 countries around the world.

Kennedy is chairman and CEO of Raytheon. He joined the company in 1983. Before being appointed chairman in October 2014, Kennedy became CEO in March 2014, and he was elected to Raytheon’s Board of Directors in January 2014.

Prior to joining Raytheon, Kennedy served in the US Air Force where he attained the rank of captain. He earned a doctorate in engineering from the University of California, Los Angeles; and bachelor’s and master’s degrees in electrical engineering from Rutgers University and the Air Force Institute of Technology, respectively.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.